# Syantra

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syantra

- Industry: Healthcare
- Headquarters: Calgary, Canada
- Website: www.syantra.com
- Total disclosed funding: $6.8M
- Latest round: Series A (Jan 20, 2022)
- Investors on record: 5

## About

Founded in 2016 and based in Alberta, Canada, Syantra Inc. operates as a healthcare facility that specializes in the early detection of breast cancer through blood testing. The company was co-founded by Dr. Tina Rinker, Dr. Ken Fuh, Dr. Randy Moore and Bob Shepherd. The company was formed via an out-performed program, a biomarker and drug target discovery platform, in Rinker Lab at University of Calgary in Canada. In 2011, the company reached partnership with Dr. Hyeyoung Lee from Yonsei University in South Korea, and developed a program that won the Alberta-Gangwon Collaborative Research Grant. In December 2021, Drs. Rinker and Fuh presented interim clinical trial results at the San Antonio Breast Cancer Symposium, based on samples from 1,107 participants (2100 participant study target).

## Funding rounds

- Series A, Jan 20, 2022, $6.8M — Plug and Play, Alberta Innovates, Accelerate Fund, Opportunity Calgary Investment Fund, Innovate Edmonton

## Investors

- Plug and Play (https://capitalatlas.ai/funds/plug-and-play) — Series A
- Alberta Innovates — Series A
- Accelerate Fund — Series A
- Opportunity Calgary Investment Fund (https://capitalatlas.ai/funds/opportunity-calgary-investment-fund) — Series A
- Innovate Edmonton — Series A